These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Update: affibody molecules for molecular imaging and therapy for cancer. Orlova A; Feldwisch J; Abrahmsén L; Tolmachev V Cancer Biother Radiopharm; 2007 Oct; 22(5):573-84. PubMed ID: 17979560 [TBL] [Abstract][Full Text] [Related]
5. Engineered affinity proteins for tumour-targeting applications. Friedman M; Ståhl S Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363 [TBL] [Abstract][Full Text] [Related]
6. Affibody molecules as engineered protein drugs. Frejd FY; Kim KT Exp Mol Med; 2017 Mar; 49(3):e306. PubMed ID: 28336959 [TBL] [Abstract][Full Text] [Related]
7. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein. Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382 [TBL] [Abstract][Full Text] [Related]
8. Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling. Fleetwood F; Güler R; Gordon E; Ståhl S; Claesson-Welsh L; Löfblom J Cell Mol Life Sci; 2016 Apr; 73(8):1671-83. PubMed ID: 26552422 [TBL] [Abstract][Full Text] [Related]
9. Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention? Baune BT Curr Opin Psychiatry; 2015 Mar; 28(2):148-54. PubMed ID: 25602246 [TBL] [Abstract][Full Text] [Related]
10. Engineering of Affibody Molecules. Ståhl S; Lindberg H; Hjelm LC; Löfblom J; Dahlsson Leitao C Cold Spring Harb Protoc; 2023 Jul; ():. PubMed ID: 37491082 [TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration. Shay J; Elbaz HA; Lee I; Zielske SP; Malek MH; Hüttemann M Oxid Med Cell Longev; 2015; 2015():181260. PubMed ID: 26180580 [TBL] [Abstract][Full Text] [Related]
12. Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties. Wållberg H; Orlova A; Altai M; Hosseinimehr SJ; Widström C; Malmberg J; Ståhl S; Tolmachev V J Nucl Med; 2011 Mar; 52(3):461-9. PubMed ID: 21321280 [TBL] [Abstract][Full Text] [Related]
13. Design of an optimized scaffold for affibody molecules. Feldwisch J; Tolmachev V; Lendel C; Herne N; Sjöberg A; Larsson B; Rosik D; Lindqvist E; Fant G; Höidén-Guthenberg I; Galli J; Jonasson P; Abrahmsén L J Mol Biol; 2010 Apr; 398(2):232-47. PubMed ID: 20226194 [TBL] [Abstract][Full Text] [Related]
14. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold. Nygren PA FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759 [TBL] [Abstract][Full Text] [Related]